[go: up one dir, main page]

IL195060A0 - Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof - Google Patents

Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Info

Publication number
IL195060A0
IL195060A0 IL195060A IL19506008A IL195060A0 IL 195060 A0 IL195060 A0 IL 195060A0 IL 195060 A IL195060 A IL 195060A IL 19506008 A IL19506008 A IL 19506008A IL 195060 A0 IL195060 A0 IL 195060A0
Authority
IL
Israel
Prior art keywords
manufacturing procedure
moisture sensitive
stable formulation
sensitive drug
drug
Prior art date
Application number
IL195060A
Other languages
English (en)
Original Assignee
Teva Pharma
Fox Michael
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma, Fox Michael filed Critical Teva Pharma
Publication of IL195060A0 publication Critical patent/IL195060A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
IL195060A 2006-06-02 2008-11-02 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof IL195060A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/021586 WO2007142628A1 (en) 2006-06-02 2006-06-02 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Publications (1)

Publication Number Publication Date
IL195060A0 true IL195060A0 (en) 2011-08-01

Family

ID=37607178

Family Applications (1)

Application Number Title Priority Date Filing Date
IL195060A IL195060A0 (en) 2006-06-02 2008-11-02 Stable formulation comprising moisture sensitive drug/s and manufacturing procedure thereof

Country Status (8)

Country Link
JP (1) JP2009538905A (es)
CN (1) CN101460191A (es)
BR (1) BRPI0621739A2 (es)
CA (1) CA2652620A1 (es)
IL (1) IL195060A0 (es)
MX (1) MX2008015343A (es)
NO (1) NO20085423L (es)
WO (1) WO2007142628A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102008020701A1 (de) 2008-04-24 2009-10-29 Bayer Technology Services Gmbh Formulierung mit reduzierter Hygroskopizität
MX370647B (es) * 2012-02-17 2019-12-19 Egyt Gyogyszervegyeszeti Gyar Formulación farmacéutica que tiene estabilidad mejorada.
FR2991179B1 (fr) * 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739690A1 (de) * 1987-11-24 1989-06-08 Hoechst Ag Stabilisierte arzneistoffe, verfahren zu ihrer herstellung sowie stabile arzneizubereitungen
DE19952030A1 (de) * 1999-10-28 2001-05-03 Basf Ag Verfahren zur Herstellung von hochreaktiven Polyisobutenen
WO2003075842A2 (en) * 2002-03-08 2003-09-18 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
US6869963B2 (en) * 2003-07-11 2005-03-22 Sandoz Ag Stable pharmaceutical compositions containing an ACE inhibitor
AR048033A1 (es) * 2004-03-12 2006-03-22 Smithkline Beecham Plc Composicion farmaceutica para moldear componentes que comprende copolimero de poli(met)acrilato, cubierta, conector o espaciador de capsula moldeado por inyeccion que tiene la composicion farmaceutica y forma de dosificacion farmaceutica de multicomponentes a partir de dicha composicion

Also Published As

Publication number Publication date
MX2008015343A (es) 2008-12-16
CN101460191A (zh) 2009-06-17
JP2009538905A (ja) 2009-11-12
BRPI0621739A2 (pt) 2011-12-20
CA2652620A1 (en) 2007-12-13
NO20085423L (no) 2009-02-25
WO2007142628A1 (en) 2007-12-13

Similar Documents

Publication Publication Date Title
PL1890681T3 (pl) Kompozycja granulowana na sucho zawierająca emtrycytabinę i tenofowir DF
DK2073795T3 (da) Misbrugssikret lægemiddelformulation
EP1882042A4 (en) COMBINED ACTIVE COMPOSITION AND ANALYZER DETECTION DEVICE
IL194688A0 (en) Rapid acting and long acting insulin combination formulations
EP2042138A4 (en) PLASTER AND PAVER PREPARATION
IL184563A (en) Pharmaceutical foam formulations and their use
IL199397A (en) Hetero-ring compounds, pharmaceuticals containing them, and their medicinal products
ZA201101477B (en) Co-crystals and pharmaceutical formulations comprising the same
IL199187A (en) Indole history, pharmaceuticals including them and their use in the manufacture of medicines
IL193678A (en) Derivatives of pyrazolyl-theophane, pharmaceuticals containing them and their use in the preparation of drugs to improve cognitive activity
IL184735A0 (en) Pharmaceutical formulations and methods of use
IL199265A (en) Oxindol derivatives are converted and used to make a drug
IL198046A (en) Metastatin derivatives and drugs that include them
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
IL188744A0 (en) High drug load formulations and dosage forms
IL194751A0 (en) Drugs and uses
IL193211A (en) Derivatives of Indzol-Troaril and pharmaceutical preparations containing them
IL193700A0 (en) Medicaments and proteins
GB2443336B (en) Spiruchostatin analogues and their medicinal use
IL192206A0 (en) Topical mecamylamine formulations for ocular administration and uses thereof
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
IL197273A0 (en) Pharmaceutical and sunscreen compositions comprising caspase-14
GB0614586D0 (en) Pharmaceutical Formulation
ZA200803574B (en) Dietary fiber formulation and method of administration
IL184034A0 (en) Clopidogrel base suitable for pharmaceutical formulation and preparation thereof